During the past decade, Centro Clinico Champalimaud; Oncologia Medica conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Clinico Champalimaud; Oncologia Medica" #1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Centro Clinico Champalimaud; Oncologia Medica" are "Breast Cancer" (3 trials), "Breast Neoplasms" (2 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Centro Clinico Champalimaud; Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Centro Clinico Champalimaud; Oncologia Medica" are "Drug" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials) and "Trastuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Clinico Champalimaud; Oncologia Medica" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Clinico Champalimaud; Oncologia Medica". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Centro Clinico Champalimaud; Oncologia Medica, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Clinico Champalimaud; Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".